UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 21, 2026
Sale
Calculated transaction value
$1.23M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 20, 2026
Public filing date
Aug 21, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$521
Aug 20, 2026
Close before public filing
$521
Aug 20, 2026
Return since public filing
-4.59%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,357 shares @ $520.46
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000125
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.24M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 20, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $506.01K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $781.34K |
| United Therapeutics Corp UTHR Current | Sale | Aug 20, 2026 | $1.23M |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $501.48K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $418.61K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $126.02K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $101.71K |
| United Therapeutics Corp UTHR | Exercise | Aug 20, 2026 | $0 |